首页> 外文期刊>The Journal of Urology >Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.
【24h】

Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.

机译:肾皮质肿瘤患者的肾静脉或下腔静脉延长:肿瘤组织学的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We determined the prognostic significance of renal vein or inferior vena caval (IVC) extension in patients with nonmetastatic renal cell carcinoma (RCC) or oncocytoma undergoing surgery. MATERIALS AND METHODS: The charts of patients undergoing radical or partial nephrectomy from 1989 to 2001 for nonmetastatic RCC or oncocytoma were retrospectively reviewed. A total of 1082 patients (1120 renal units) underwent radical (850 renal units) or partial (270 renal units) nephrectomy. RESULTS: Renal vein extension was present in 60 patients (65.9%) and IVC extension was present in 31 (34.1%). The histological type associated with an increased risk of renal vein/IVC extension was conventional (80 of 702 cases, p <0.0001) and histological types with a decreased risk were oncocytoma (0 of 117, p = 0.00052) and papillary histology (0 of 146, p <0.0001). The 5-year actuarial recurrence-free probability was 59%, 65% and 91% in patients with IVC extension, renal vein extension and no renal vein or IVC extension, respectively. Larger tumor size, nodal metastases and conventional histology were associated with an increased risk of recurrence (RR = 3.38, 95% CI 2.53 to 4.51 for a doubling in size, RR = 9.97, 95% CI 5.51 to 18.1 and RR 3.78, 95% CI 2.15 to 6.65) as well as death (RR = 1.44, 95% CI 1.20 to 1.74 for a doubling in size, RR = 5.39, 95% CI 2.86 to 10.2 and RR = 1.56, 95% CI 1.09 to 2.24, respectively). CONCLUSIONS: Conventional RCC is associated with an increased risk, and oncocytoma and papillary histology are associated with a decreased risk of renal vein or IVC extension. Renal vein or IVC extension alone does not impart a worse prognosis independent of tumor size, nodal status and histology.
机译:目的:我们确定了非转移性肾细胞癌(RCC)或正在接受手术的肿瘤细胞瘤患者的肾静脉或下腔静脉(IVC)延长的预后意义。材料与方法:回顾性分析了1989年至2001年因非转移性RCC或肿瘤细胞瘤接受根治性或部分肾切除术的患者的病历。共有1082例患者(1120个肾脏单位)接受了根治性(850个肾脏单位)或部分(270个肾脏单位)肾切除术。结果:60例患者出现了肾静脉延长(65.9%),而31例出现了IVC延长(34.1%)。与肾静脉/ IVC延伸风险增加相关的组织学类型是常规的(702例中有80例,p <0.0001),风险降低的组织学类型是恶性肿瘤(0 of 117,p = 0.00052)和乳头状组织学(0例146,p <0.0001)。 IVC延长,肾静脉延长和无肾静脉或IVC延长的患者的5年无精算复发率分别为59%,65%和91%。更大的肿瘤大小,淋巴结转移和常规组织学与复发风险增加相关(RR = 3.38,95%CI 2.53至4.51倍增,RR = 9.97,95%CI 5.51至18.1和RR 3.78,95% CI 2.15至6.65)以及死亡(尺寸翻倍时RR = 1.44、95%CI 1.20至1.74,RR = 5.39、95%CI 2.86至10.2和RR = 1.56、95%CI 1.09至2.24) 。结论:常规RCC与增加的风险相关,而肿瘤细胞瘤和乳头组织学与降低肾静脉或IVC延伸的风险相关。单独的肾静脉或IVC延伸并不赋予更坏的预后,而与肿瘤大小,淋巴结状态和组织学无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号